Assignee
ONCOONE RES & DEVELOPMENT GMBH
AT·0 granted patents·5 pending applications·0 citations·filing 2019–2022
Top patents by PatentIndex Score
5 records- 0151US2023365671A1IMPROVED ANTI-oxMIF ANTIBODIES WITH REDUCED AGGREGATION POTENTIAL AND REDUCED HYDROPHOBICITYONCOONE RES & DEVELOPMENT GMBH·Filed 2021·Application pending·0 cites
- 0248US2025129148A1IMPROVED Fc SILENCED ANTI-oxMIF ANTIBODIES WITH REDUCED AGGREGATION POTENTIAL AND REDUCED HYDROPHOBICITYONCOONE RES & DEVELOPMENT GMBH·Filed 2022·Application pending·0 cites
- 0346US2024307562A1ANTI-oxMIF RADIOIMMUNOCONJUGATEONCOONE RES & DEVELOPMENT GMBH·Filed 2022·Application pending·0 cites
- 0444US2023045873A1ANTI-oxMIF/ANTI-CD3 BISPECIFIC ANTIBODY CONSTRUCTSONCOONE RES & DEVELOPMENT GMBH·Filed 2020·Application pending·0 cites
- 0539US2022002398A1ANTI-oxMIF/ANTI-CD3 ANTIBODY FOR CANCER TREATMENTONCOONE RES & DEVELOPMENT GMBH·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ONCOONE RES & DEVELOPMENT GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →